Viewing Study NCT07424833


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 3:10 PM
Study NCT ID: NCT07424833
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-20
First Post: 2026-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Sponsor: Ascentage Pharma Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module